|1.||Walsh, Thomas J: 18 articles (02/2014 - 06/2003)|
|2.||Harrison, Thomas S: 16 articles (01/2015 - 05/2004)|
|3.||Sobel, Jack D: 16 articles (12/2012 - 11/2002)|
|4.||Manzoni, Paolo: 15 articles (05/2014 - 01/2006)|
|5.||Cornely, Oliver A: 13 articles (01/2015 - 08/2006)|
|6.||Gupta, Aditya K: 12 articles (09/2015 - 01/2003)|
|7.||Perfect, John R: 12 articles (01/2015 - 11/2004)|
|8.||Benjamin, Daniel K: 11 articles (07/2015 - 08/2006)|
|9.||Kontoyiannis, Dimitrios P: 11 articles (11/2014 - 04/2002)|
|10.||Marr, Kieren A: 11 articles (09/2013 - 05/2002)|
12/01/2014 - "Most patients with C albicans infections can be successfully treated with maintenance antifungal therapy, usually with fluconazole. "
12/01/2014 - "Efficacy of prophylactic fluconazole therapy in decreasing the incidence of Candida infections in extremely low birth weight preterm infants."
04/01/2010 - "Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants."
01/01/2007 - "Its emergence spectrum varies from mucosal to systemic infections and the first line treatment is still based on fluconazole, a triazole derivate with a potent antifungal activity against most of C. "
02/01/2004 - "Prophylaxis by fluconazole has dramatically reduced the frequency of early Candida infections. "
04/01/1990 - "In summary, fluconazole was most effective against disseminated candidiasis in persistently granulocytopenic rabbits when used for prevention or early treatment."
04/01/1990 - "Fluconazole was most effective when used for preventive or early treatment of acute and subacute disseminated candidiasis. "
10/01/2011 - "In the treatment of oropharyngeal candidiasis, E1210 and fluconazole each caused a significantly greater reduction in the number of oral CFU than the control treatment (P < 0.05). "
08/01/1991 - "Fluconazole is a safe and effective agent with significant activity against chronic disseminated candidiasis."
11/01/1990 - "The convenience, good tolerance and clinical efficacy of fluconazole make it the therapy of choice for oropharyngeal candidiasis in immunologically compromised patients."
|3.||Acquired Immunodeficiency Syndrome (AIDS)
07/01/1994 - "High-dose fluconazole appears safe and effective for cryptococcal disease in AIDS patients."
02/01/1996 - "Improved standardization of fluconazole susceptibility testing has resulted in demonstrable correlations between yeast resistance in vitro and in vivo for this agent in the AIDS setting. "
06/01/1991 - "Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS."
09/01/2008 - "This study was designed to investigate the: existence of OPC, species distribution fluconazole susceptibility profile of yeast cells isolated from oral specimens of HIV/AIDS patients from Lagos Nigeria, between Oct. "
10/01/2002 - "This study provides important baseline data as the isolates were collected prior to fluconazole being made freely available to HIV/AIDS patients attending government health clinics."
03/01/1992 - "Fluconazole is highly effective in suppressing relapses of cryptococcal meningitis. "
01/01/2011 - "Improved strategies for earlier diagnosis and treatment of HIV, implementation of fluconazole pre-emptive treatment for high-risk patients and acquisition of better resources for treatment of cryptococcal meningitis are needed."
07/01/1994 - "Eight patients (6, cryptococcal meningitis; 2, high-titer cryptococcal antigenemia) were treated with 800 mg/day fluconazole to assess the safety and efficacy of high-dose fluconazole as primary therapy. "
03/01/1992 - "Fluconazole, an orally active antifungal agent, has been shown to be clinically beneficial for maintenance therapy of cryptococcal meningitis. "
03/04/1995 - "Although the optimum dose and duration of fluconazole could not be determined, our results suggest that less than daily use was effective in the prevention of cryptococcal meningitis."
08/01/1986 - "Fluconazole was highly effective in suppressing cryptococcosis in mice challenged by the intravenous and intranasal routes, and was comparable with the other two drugs in its protective capacity. "
06/15/2003 - "Fluconazole is useful in the treatment of CNS cryptococcosis, because it attains high concentration in the CNS. "
09/01/2006 - "Fluconazole is effective in the treatment of pulmonary cryptococcosis in these patients."
01/01/1995 - "Treatment with fluconazole was effective in 2 months on the cryptococcosis. "
01/01/1992 - "In primary treatment of cryptococcosis, fluconazole is well tolerated, but is effective in only 50% of patients. "
|2.||Amphotericin B (Amphotericin)
|1.||Drug Therapy (Chemotherapy)
|4.||Transplantation (Transplant Recipients)